CollPlant Biotechnologies Ltd - SHS NEW (CLGN)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / SHS NEW
Number of holders
18
Total 13F shares, excl. options
1,553,516
Shares change
-166,859
Total reported value, excl. options
$10,590,000
Value change
-$1,725,358
Number of buys
8
Number of sells
-7
Price
$6.80

Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q3 2022

21 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q3 2022.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,553,516 shares .
Largest 10 shareholders include Roumell Asset Management, LLC (605,437 shares), INVESTMENT MANAGEMENT OF VIRGINIA LLC (403,573 shares), VILLERE ST DENIS J & CO LLC (286,197 shares), BROWN ADVISORY INC (73,849 shares), BENJAMIN F. EDWARDS & COMPANY, INC. (65,410 shares), LPL Financial LLC (28,070 shares), Zurcher Kantonalbank (Zurich Cantonalbank) (23,190 shares), SIMON QUICK ADVISORS, LLC (15,676 shares), JANE STREET GROUP, LLC (13,265 shares), and Private Advisor Group, LLC (12,862 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.